PharmaShots | Incisive News in 3 Shots

Subscribe Now

Astrazeneca

AstraZeneca Reports Data from the P-III (WAYPOINT) Study of Tezspire (Tezepelumab) for Chronic Rhinosinusitis with Nasal Polyps

AstraZeneca Reports Data from the P-III (WAYPOINT) Study of Tezspire (Tezepelumab) for Chronic Rhinosinusitis with Nasal Polyps

November 8, 2024

AstraZeneca’s Fasenra Receives EU Approval for Eosinophilic Granulomatosis with Polyangiitis

AstraZeneca’s Fasenra Receives EU Approval for Eosinophilic Granulomatosis with Polyangiitis

October 29, 2024

AstraZeneca at ERA’24: Mina Makar in a Stimulating Conversation with PharmaShots

AstraZeneca at ERA’24: Mina Makar in a Stimulating Conversation with PharmaShots

October 28, 2024

AstraZeneca and Ionis’ Wainzua (Eplontersen) Receives the CHMP’s Positive Opinion to Treat Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy

AstraZeneca and Ionis’ Wainzua (Eplontersen) Receives the CHMP’s Positive Opinion to Treat Hereditary Transthyretin-Mediated Amylo...

October 21, 2024

AstraZeneca and Daiichi Sankyo Report the NMPA’s Conditional Approval of Enhertu to Treat Metastatic NSCLC with HER2 Mutations

AstraZeneca and Daiichi Sankyo Report the NMPA’s Conditional Approval of Enhertu to Treat Metastatic NSCLC with HER2 Mutations

October 14, 2024

PharmaShots Weekly Snapshots (October 07 – October 11, 2024)

PharmaShots Weekly Snapshots (October 07 – October 11, 2024)

October 11, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us